aluates Reports

$ 0.0

Automative

Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-7W2422

Global Spinal Muscular Atrophy SMA Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report 2025

Code: QYRE-Auto-7W2422

Report

September 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Isis Pharmaceuticals

Biogen Idec

Boehringer Ingelheim

F.Hoffmann-La Roche

Regeneron Pharmaceuticals

Spinal Muscular Atrophy (SMA) Treatment Market Size

The global market for Spinal Muscular Atrophy (SMA) Treatment was valued at US$ 1080 million in the year 2024 and is projected to reach a revised size of US$ 1757 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Spinal Muscular Atrophy (SMA) Treatment Market

Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy (SMA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy (SMA) Treatment.

The Spinal Muscular Atrophy (SMA) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spinal Muscular Atrophy (SMA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Spinal Muscular Atrophy (SMA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Spinal Muscular Atrophy (SMA) Treatment Market Report

Report Metric	Details
Report Name	Spinal Muscular Atrophy (SMA) Treatment Market
Accounted market size in year	US$ 1080 million
Forecasted market size in 2031	US$ 1757 million
CAGR	7.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Type I Spinal Muscular Atrophy (SMA) Type II Spinal Muscular Atrophy (SMA) Type III Spinal Muscular Atrophy (SMA)
Segment by Application	Hospitals Ambulatory Surgical Centers Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Isis Pharmaceuticals, Biogen Idec, Boehringer Ingelheim, F. Hoffmann-La Roche, Regeneron Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy (SMA) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Spinal Muscular Atrophy (SMA) Treatment Market growing?

Ans: The Spinal Muscular Atrophy (SMA) Treatment Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Spinal Muscular Atrophy (SMA) Treatment Market size in 2031?

Ans: The Spinal Muscular Atrophy (SMA) Treatment Market size in 2031 will be US$ 1757 million.

Who are the main players in the Spinal Muscular Atrophy (SMA) Treatment Market report?

Ans: The main players in the Spinal Muscular Atrophy (SMA) Treatment Market are Pfizer, Isis Pharmaceuticals, Biogen Idec, Boehringer Ingelheim, F. Hoffmann-La Roche, Regeneron Pharmaceuticals

What are the Application segmentation covered in the Spinal Muscular Atrophy (SMA) Treatment Market report?

Ans: The Applications covered in the Spinal Muscular Atrophy (SMA) Treatment Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others

What are the Type segmentation covered in the Spinal Muscular Atrophy (SMA) Treatment Market report?

Ans: The Types covered in the Spinal Muscular Atrophy (SMA) Treatment Market report are Type I Spinal Muscular Atrophy (SMA), Type II Spinal Muscular Atrophy (SMA), Type III Spinal Muscular Atrophy (SMA)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Type I Spinal Muscular Atrophy (SMA)

1.2.3 Type II Spinal Muscular Atrophy (SMA)

1.2.4 Type III Spinal Muscular Atrophy (SMA)

1.3 Market by Application

1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Perspective (2020-2031)

2.2 Global Spinal Muscular Atrophy (SMA) Treatment Growth Trends by Region

2.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Spinal Muscular Atrophy (SMA) Treatment Market Dynamics

2.3.1 Spinal Muscular Atrophy (SMA) Treatment Industry Trends

2.3.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers

2.3.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges

2.3.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue

3.1.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue (2020-2025)

3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Spinal Muscular Atrophy (SMA) Treatment Revenue

3.4 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio

3.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2024

3.5 Global Key Players of Spinal Muscular Atrophy (SMA) Treatment Head office and Area Served

3.6 Global Key Players of Spinal Muscular Atrophy (SMA) Treatment, Product and Application

3.7 Global Key Players of Spinal Muscular Atrophy (SMA) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Type

4.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2026-2031)

5 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Application

5.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2020-2031)

6.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025)

6.4 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2020-2031)

7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025)

7.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2020-2031)

9.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025)

9.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction

11.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Isis Pharmaceuticals

11.2.1 Isis Pharmaceuticals Company Details

11.2.2 Isis Pharmaceuticals Business Overview

11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction

11.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.2.5 Isis Pharmaceuticals Recent Development

11.3 Biogen Idec

11.3.1 Biogen Idec Company Details

11.3.2 Biogen Idec Business Overview

11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction

11.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.3.5 Biogen Idec Recent Development

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Details

11.4.2 Boehringer Ingelheim Business Overview

11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction

11.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.4.5 Boehringer Ingelheim Recent Development

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Details

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Recent Development

11.6 Regeneron Pharmaceuticals

11.6.1 Regeneron Pharmaceuticals Company Details

11.6.2 Regeneron Pharmaceuticals Business Overview

11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction

11.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

11.6.5 Regeneron Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Isis Pharmaceuticals

Biogen Idec

Boehringer Ingelheim

F.Hoffmann-La Roche

Regeneron Pharmaceuticals

List of Tables

Table 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Type I Spinal Muscular Atrophy (SMA)

Table 3. Key Players of Type II Spinal Muscular Atrophy (SMA)

Table 4. Key Players of Type III Spinal Muscular Atrophy (SMA)

Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2020-2025)

Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2026-2031)

Table 11. Spinal Muscular Atrophy (SMA) Treatment Market Trends

Table 12. Spinal Muscular Atrophy (SMA) Treatment Market Drivers

Table 13. Spinal Muscular Atrophy (SMA) Treatment Market Challenges

Table 14. Spinal Muscular Atrophy (SMA) Treatment Market Restraints

Table 15. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players (2020-2025)

Table 17. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2024)

Table 18. Ranking of Global Top Spinal Muscular Atrophy (SMA) Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Spinal Muscular Atrophy (SMA) Treatment, Headquarters and Area Served

Table 21. Global Key Players of Spinal Muscular Atrophy (SMA) Treatment, Product and Application

Table 22. Global Key Players of Spinal Muscular Atrophy (SMA) Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product

Table 50. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Isis Pharmaceuticals Company Details

Table 53. Isis Pharmaceuticals Business Overview

Table 54. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product

Table 55. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 56. Isis Pharmaceuticals Recent Development

Table 57. Biogen Idec Company Details

Table 58. Biogen Idec Business Overview

Table 59. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product

Table 60. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 61. Biogen Idec Recent Development

Table 62. Boehringer Ingelheim Company Details

Table 63. Boehringer Ingelheim Business Overview

Table 64. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product

Table 65. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 66. Boehringer Ingelheim Recent Development

Table 67. F. Hoffmann-La Roche Company Details

Table 68. F. Hoffmann-La Roche Business Overview

Table 69. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product

Table 70. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 71. F. Hoffmann-La Roche Recent Development

Table 72. Regeneron Pharmaceuticals Company Details

Table 73. Regeneron Pharmaceuticals Business Overview

Table 74. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product

Table 75. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025) & (US$ Million)

Table 76. Regeneron Pharmaceuticals Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Spinal Muscular Atrophy (SMA) Treatment Picture

Figure 2. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Type I Spinal Muscular Atrophy (SMA) Features

Figure 5. Type II Spinal Muscular Atrophy (SMA) Features

Figure 6. Type III Spinal Muscular Atrophy (SMA) Features

Figure 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Ambulatory Surgical Centers Case Studies

Figure 11. Diagnostic Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered

Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Spinal Muscular Atrophy (SMA) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region: 2024 VS 2031

Figure 17. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players in 2024

Figure 18. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2024

Figure 20. North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2020-2031)

Figure 22. United States Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2020-2031)

Figure 26. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2020-2031)

Figure 34. China Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2020-2031)

Figure 42. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2020-2031)

Figure 46. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 50. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 51. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Spinal Muscular Atrophy SMA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spinal Muscular Atrophy SMA Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injections for SMA Market Research Report 2024

Global Drugs for Spinal Muscular Atrophy SMA Market Research Report 2024

Spinal and Bulbar Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spinal Muscular Atrophy Genetic Detection Market Research Report 2024

Global Spinal Muscular Atrophy Medicine Market Research Report 2025

Global Nusinersen Market Research Report 2024

Global Sarcopenia Treatments Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Bulbospinal Muscular Atrophy Drugs Market Research Report 2024

Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030

Sarcopenia Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myasthenia Gravis Therapies Market Research Report 2024

Global Musculoskeletal System Disorder Therapeutics Market Research Report 2024

Global Shape Memory Alloy SMA Actuator Market Research Report 2024

Global Neurodegenerative Disease Market Insights Forecast to 2030

Sarcopenia Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global SMA Actuator Market Research Report 2024

Global Myotonic Dystrophy Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions